Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 12:12:713880.
doi: 10.3389/fendo.2021.713880. eCollection 2021.

The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls

Affiliations

The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls

Ruixue Cao et al. Front Endocrinol (Lausanne). .

Abstract

Objective: The present study aimed to assess the diagnostic utility of the Luteinizing hormone (LH) levels and single 60-minute post gonadotropin-releasing hormone (GnRH) agonist stimulation test for idiopathic central precocious puberty (CPP) in girls.

Methods: Data from 1,492 girls diagnosed with precocious puberty who underwent GnRH agonist stimulation testing between January 1, 2016, and October 8, 2020, were retrospectively reviewed. LH levels and LH/follicle-stimulating hormone (FSH) ratios were measured by immuno-chemiluminescence assay before and at several timepoints after GnRH analogue stimulation testing. Mann-Whitney U test, Spearman's correlation, χ2 test, and receiver operating characteristic (ROC) analyses were performed to determine the diagnostic utility of these hormone levels.

Results: The 1,492 subjects were split into two groups: an idiopathic CPP group (n = 518) and a non-CPP group (n = 974). Basal LH levels and LH/FSH ratios were significantly different between the two groups at 30, 60, 90, and 120 minutes after GnRH analogue stimulation testing. Spearman's correlation analysis showed the strongest correlation between peak LH and LH levels at 60 minutes after GnRH agonist stimulation (r = 0.986, P < 0.001). ROC curve analysis revealed that the 60-minute LH/FSH ratio yielded the highest consistency, with an area under the ROC curve (AUC) of 0.988 (95% confidence interval [CI], 0.982-0.993) and a cut-off point of 0.603 mIU/L (sensitivity 97.3%, specificity 93.0%). The cut-off points of basal LH and LH/FSH were 0.255 mIU/L (sensitivity 68.9%, specificity 86.0%) and 0.07 (sensitivity 73.2%, specificity 89.5%), respectively, with AUCs of 0.823 (95% CI, 0.799-0.847) and 0.843 (95% CI, 0.819-0.867), respectively.

Conclusions: A basal LH value greater than 0.535 mIU/L can be used to diagnose CPP without a GnRH agonist stimulation test. A single 60-minute post-stimulus gonadotropin result of LH and LH/FSH can be used instead of a GnRH agonist stimulation test, or samples can be taken only at 0, 30, and 60 minutes after a GnRH agonist stimulation test. This reduces the number of blood draws required compared with the traditional stimulation test, while still achieving a high level of diagnostic accuracy.

Keywords: GnRH agonist stimulation test; central precocious puberty; follicle-stimulating hormone; luteinizing hormone; pediatrics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Spearman’s correlation results between peak LH and the level at 0, 60, 90, and 120 minutes after GnRH agonist stimulation. (B) Spearman’s correlation results between peak LH/FSH ratio levels and the level at 0, 60, 90, and 120 minutes after GnRH agonist stimulation.
Figure 2
Figure 2
ROC curves used to evaluate the sensitivity and specificity at each level for LH and LH/FSH post GnRH agonist stimulus.

Similar articles

Cited by

References

    1. Latronico AC, Brito VN, Carel JC. Causes, Diagnosis, and Treatment of Central Precocious Puberty. Lancet Diabetes Endocrinol (2016) 4(3):265–74. 10.1016/S2213-8587(15)00380-0 - DOI - PubMed
    1. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group et al. . Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children. Pediatrics (2009) 123(4):e752–62. 10.1542/peds.2008-1783 - DOI - PubMed
    1. Houk CP, Kunselman AR, Lee PA. Adequacy of a Single Unstimulated Luteinizing Hormone Level to Diagnose Central Precocious Puberty in Girls. Pediatrics (2009) 123(6):e1059–63. 10.1542/peds.2008-1180 - DOI - PubMed
    1. Lee HS, Park HK, Ko JH, Kim YJ, Hwang JS. Utility of Basal Luteinizing Hormone Levels for Detecting Central Precocious Puberty in Girls. Horm Metab Res (2012) 44(11):851–4. 10.1055/s-0032-1321905 - DOI - PubMed
    1. Houk CP, Kunselman AR, Lee PA. The Diagnostic Value of a Brief Gnrh Analogue Stimulation Test in Girls With Central Precocious Puberty: A Single 30-Minute Post-Stimulation LH Sample Is Adequate. J Pediatr Endocrinol Metab (2008) 21(12):1113–8. 10.1515/JPEM.2008.21.12.1113 - DOI - PubMed

LinkOut - more resources